DYNPORT VACCINE COMPANY LLC
FREDERICK, Maryland
Total Received
$1.21B
Total Awards
14
State
Maryland
Last Updated
Jan 14, 2026
Yearly Funding Trend
$979.0M24
$235.3M25
Top 14 Awards to DYNPORT VACCINE COMPANY LLC
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through January 14, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_DAMD1798C8024_9700_-NONE-_-NONE- 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP… | Department of Defense Defense Contract Management Agency | — | FREDERICK, MD-06 | 2024 | $806,269,061 |
CONT_AWD_HHSO100200600013C_7505_-NONE-_-NONE- CLOSE CONTRACT AND DEOBLIGATE EXCESS FUNDS | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | FREDERICK, MD-06 | 2025 | $235,119,971 |
CONT_AWD_W911QY13C0056_9700_-NONE-_-NONE- EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 12 MARCH 2026 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS. | Department of Defense Department of the Army | — | FREDERICK, MD-06 | 2024 | $117,632,941 |
CONT_AWD_0002_9700_W81XWH15D0037_9700 R&D - OPHTHALMIC SAFETY OF TQ VS PLACEBO | Department of Defense Defense Health Agency | — | — | 2024 | $24,238,921 |
CONT_AWD_W911QY21C0093_9700_-NONE-_-NONE- PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). | Department of Defense Department of the Army | — | FREDERICK, MD-06 | 2024 | $14,351,309 |
CONT_AWD_75N93022F00057_7529_HHSN272201500005I_7529 PHASE I TASK AREA B -21-0013 - BASE | Department of Health and Human Services National Institutes of Health | — | FREDERICK, MD-06 | 2024 | $5,167,891 |
CONT_AWD_75N93021F00202_7529_HHSN272201500005I_7529 PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES | Department of Health and Human Services National Institutes of Health | — | FREDERICK, MD-06 | 2024 | $4,120,677 |
CONT_AWD_HHSN27200006_7529_HHSN272201500005I_7529 PHASE 1 STUDY TASK AREA B | Department of Health and Human Services National Institutes of Health | — | DURHAM, NC-04 | 2024 | $3,860,187 |
CONT_AWD_75N93023F00001_7529_75N93022D00016_7529 EPCTU | Department of Health and Human Services National Institutes of Health | — | FREDERICK, MD-06 | 2024 | $2,265,501 |
CONT_AWD_75N93022F00001_7529_75N93022D00016_7529 TASK ORDER 75N93022F00001 BASE AWARD | Department of Health and Human Services National Institutes of Health | — | FREDERICK, MD-06 | 2024 | $1,028,570 |
CONT_AWD_75N93020F00001_7529_HHSN272201500005I_7529 1500005I DYNPORT VACCINE COMPANY | Department of Health and Human Services National Institutes of Health | — | FREDERICK, MD-06 | 2025 | $129,318 |
CONT_AWD_75N93019F00125_7529_HHSN272201500005I_7529 TASK AREA A | Department of Health and Human Services National Institutes of Health | — | FREDERICK, MD-06 | 2024 | $99,979 |
CONT_IDV_75N93025D00025_7529 "EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES. | Department of Health and Human Services National Institutes of Health | — | — | 2025 | $10,000 |
CONT_IDV_75N93022D00016_7529 EARLY PHASE CLINICAL TRIAL UNITS (EPCTU) | Department of Health and Human Services National Institutes of Health | — | — | 2024 | $0 |
Top 14 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→1234
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$235.1M
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY$131.0M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)$24.2M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$17.7M
Source: USAspending.gov · All Recipients · Maryland